Improve CLL Sales Fluency with myHCP
Dr. Sarah Chen
Hematologic Oncologist
Favors venetoclax-based fixed-duration combinations
Academic physician focused on evidence-based CLL treatment at a major medical center.
Dr. Michael Rodriguez
Hematologic Oncologist
Uses ibrutinib but hasn't tried Brukinsa (zanubrutinib)
Community oncologist with extensive ibrutinib experience seeking to learn about newer options.
Dr. Emma Patel
Hematologic Oncologist
Seeks to understand optimal therapy selection for each patient
Early-career oncologist with strong academic background in personalized medicine.
Jennifer Martinez
Nurse Practitioner
Prioritizes adherence, administration support, and cost management
Experienced NP focused on patient support, medication adherence, and financial assistance.